The classification of adenohypophysial neoplasms as “pituitary neuroendocrine
tumors”(PitNETs) was proposed in 2017 to reflect their characteristics as epithelial …

The classification of neoplasms of adenohypophysial cells is misleading because of the
simplistic distinction between adenoma and carcinoma, based solely on metastatic spread …

Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors
(PitNET), are mostly benign, but may present various behaviors: invasive,“aggressive” and …

In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …

Neuroendocrine tumours of the adenohypophysis have traditionally been designated as
pituitary adenomas to underline their usually indolent growth and lack of metastatic …

Abstract The 2017 World Health Organization (WHO) classification proposes to type and
subtype primary adenohypophyseal tumours according to their cell lineages with the aim to …

We read with interest “A tale of pituitary adenomas: to NET or not to NET” published in
Pituitary [1]. The members of the International Pituitary Pathology Club (IPPC) who proposed …

This review summarizes the changes in the 5th Edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the pituitary gland. The new …

The classification of tumours of the pituitary gland has recently been revised in the 2021 5th
edition World Health Organization (WHO) Classification of Central Nervous System Tumours …

Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related
to hypersecretion of adenohypophyseal hormones and are clinically characterized by …